companydata.dkcompanydata.dk

PHARMADVICE ApS: Financial statements 2022

CVR: 26527651

Source: annual report 2022, Danish Business Authority

01/01/202231/12/2022

PHARMADVICE ApS (CVR 26527651) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,311,830 and a net result of DKK 717,002 compared with DKK 275,923 the year before. That is an increase of 35.2% compared with the year before. Equity in the 2022 report amounted to DKK 1,531,298. The solvency ratio was 67%. The company had 6 employees in the financial year.

Gross Profit
DKK 5,311,830
Profit/Loss
DKK 717,002
Equity
DKK 1,531,298
Total Assets
DKK 2,284,771
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-5.3 mio.717 t.1.5 mio.6
2021-3.9 mio.276 t.839 t.5
2020-4.2 mio.309 t.1 mio.5
2019-4.6 mio.-28 t.704 t.7
2018-3.8 mio.-55 t.832 t.6

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PHARMADVICE ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

PHARMADVICE ApS: The 2021 annual report is outJun 17, 2022

PHARMADVICE ApS has published its annual report for 2021. Gross profit came to DKK 3,927,622, and the net result was DKK 275,923.

About PHARMADVICE ApS

PHARMADVICE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2002. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Susanne Ølsgaard Felumb. The company is owned by Felumb Holding ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. Equity in the 2025 report amounted to DKK 1,402,268.

Source: annual report 2025, Danish Business Authority